About Oscotec
Oscotec is a company based in Cheonan (South Korea) founded in 1998. The company has 51 employees as of December 31, 2024. Oscotec operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Cheonan, South Korea
- Employees 51 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oscotec Inc.
-
Annual Revenue
$23.06 M (USD)586.89as on Dec 31, 2024
-
Net Profit
$594.29 K (USD)0as on Dec 31, 2024
-
EBITDA
-$539.29 K (USD)97.42as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
51
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Oscotec
Oscotec is a publicly listed company on the KRX with ticker symbol 039200 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Oscotec
Detailed funding history for Oscotec
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oscotec
Investment portfolio details for Oscotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oscotec
Detailed financials for Oscotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oscotec Comparisons
Peer comparison for Oscotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oscotec
Oscotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
Detailed competitors of Oscotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oscotec
Complete news archive for Oscotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oscotec
Oscotec was founded in 1998.
Oscotec is headquartered in Cheonan, South Korea. It is registered at Cheonan, Chungcheongnam-do, South Korea.
As of Dec 31, 2024, the latest employee count at Oscotec is 51.
Annual revenue of Oscotec is $23.06M as on Dec 31, 2024.
Oscotec was founded in 1998 as a clinical-stage biopharmaceutical company based in Cheonan, South Korea. Small molecule therapeutics targeting arthritis and cancer indications are developed by the firm. Three candidates are advancing through clinical trials: SKI-O-703, an SYK inhibitor for rheumatoid arthritis; SKI-O-801, an FLT3 inhibitor for acute myeloid leukemia; and GNS-1480, an EGFR inhibitor for non-small cell lung cancer. Operations focus on oncology and immunology sectors.
Oscotec's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Yes, Oscotec is publicly traded on KRX under the ticker symbol 039200.
The ticker symbol of Oscotec is 039200 on KRX.